Call Us: +916355202656
Imanib 400mg Tablet

Imanib 400mg Tablet

500-800 INR/Box

Product Details:

  • Drug Type Specific Drug
  • Ingredients Imatinib mesylate (400mg)
  • Physical Form Tablets
  • Recommended For Cancer treatment
  • Suitable For Suitable For All
  • Quantity 100 Boxes
  • Storage Instructions Room temprature
  • Supply Ability : 100 Box Per Week
  • Click to view more
X

Price And Quantity

  • 500.00 - 1000.00 INR/Box
  • 10 Box
  • 500-800 INR/Box

Product Specifications

  • Room temprature
  • Cancer treatment
  • Imatinib mesylate (400mg)
  • 100 Boxes
  • Suitable For All
  • Tablets
  • Specific Drug

Trade Information

  • Mumbai,Surat
  • Paypal, Western Union, Telegraphic Transfer (T/T), Letter of Credit (L/C), Cash in Advance (CID), Cash on Delivery (COD)
  • 100 Box Per Week
  • 1 Week
  • Contact us for information regarding our sample policy
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Imanib 400mg Tablet belongs to the class of medicines known as tyrosine kinase inhibitors. It is used in the treatment of blood cancer (chronic myeloid leukaemia and Acute lymphocytic leukemia) and gastrointestinal stromal tumor.

Imanib 400mg Tablet should be taken with food, but better to have it same time every day to get the most benefit. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

PHARMAX LIFESCIENCES

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Listen to the Code(Audio Link)


Back to top
PHARMAX LIFESCIENCES All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.